Page 25

2026-05-08 · 2026-05 / week-1

CyanConnode Still Trades Like Esyasoft Can Walk

Summary: CyanConnode trades at 7.85p against Esyasoft's 10.44p revised possible cash offer, even after the board said it would be willing to recommend that price if a firm offer is made. The discount is not a simple merg...

2026-05-07 · 2026-05 / week-1

Skycorp Is Pricing Scarcity as Validation

Summary: PN is no longer just a small solar-cable issuer with fresh financing. The public quote is pricing a tiny unlocked float, while the last two PIPE rounds and the Nanjing Cesun acquisition consideration were struck...

2026-05-07 · 2026-05 / week-1

Rising Dragon Is Pricing a Jammed Redemption Door

Summary: Rising Dragon Acquisition trades far below its last reported trust value, but the discount is not clean cash. The market is pricing the public shares as if the redemption door is either operationally jammed or t...

2026-05-07 · 2026-05 / week-1

Herald Is Pricing the Saba Exit Below the Cash Door

Why this one now: The agreement was announced today, the quote still shows a discount to published NAV, and the payoff has moved from passive discount speculation to a specific cash-option mechanism.

2026-05-07 · 2026-05 / week-1

Greenlane Is Pricing Berachain Below Its Own Treasury

Summary: GNLN is trading like a distressed microcap that happens to own crypto. The harder read is that Greenlane now looks more like a public Berachain treasury: the common equity market cap is far below the marked valu...

2026-05-07 · 2026-05 / week-1

GeoVax Is Pricing the Vaccine, but the Vote Prices Supply

Summary: GeoVax rallied into a vaccine story while a June 17 stockholder vote sits in plain sight. The market price is now between two warrant strikes: $1.36 supply below the tape and $2.31 supply above it.

2026-05-07 · 2026-05 / week-1

Cellectar Is Trading Above Its Warrant Call Line

Summary: Cellectar's clinical update is real, but the common stock is now trading above the mechanical level that can turn the financing into a wall of $2.65 stock. The disagreement is not whether iopofosine I 131 has en...

2026-05-07 · 2026-05 / week-1

Avalo Is Pricing Phase 3 Before the Share Count Settles

Summary: AVTX now trades as if the positive Phase 2 LOTUS readout has already crossed the bridge into a funded Phase 3 story. The harder mispricing is that the $21.81 quote sits 22.9% above a $17.75 overnight offering wh...

2026-05-06 · 2026-05 / week-1

Stratus Is Pricing the Liquidation Floor

Summary: Stratus Properties is asking holders to approve a complete liquidation on June 1. The stock is trading at $29.68, almost exactly at the company's estimated low-end liquidating distribution of $29.73, while the h...

2026-05-06 · 2026-05 / week-1

Rumble Is Pricing AI Approval, but Northern Data Owns the Float

Summary: Rumble has cleared the last regulatory condition for the Northern Data exchange offer, and the stock is still trading like the deal is mainly an AI capacity win. The harder setup is mechanical: the offer documen...